GLP-1 Weight Loss Medications in Oregon

Oregon has a unique Medicaid structure. The Oregon Health Plan uses a prioritized list to determine which services are covered, ranking conditions and treatments by effectiveness and value. GLP-1 medications for type 2 diabetes are covered. Weight management coverage depends on where obesity treatment falls on the prioritized list, which is updated periodically by the Health Evidence Review Commission. CCOs have some flexibility in going beyond the prioritized list for individual patients.

Oregon spans from the dense Portland metro to remote eastern Oregon ranching communities. Telehealth parity ensures that virtual visits are covered at the same rate as in-person care. Portland has a high density of obesity medicine specialists, but central and eastern Oregon have significant provider shortages. The Oregon Telehealth Alliance coordinates resources to improve access in underserved areas.

Kaiser Permanente Northwest is a significant player in Oregon healthcare, serving over 600,000 members in the Portland-Vancouver metro. Their integrated model means that when Kaiser covers a GLP-1 medication, the prescription, provider visits, and lab work are all coordinated within the system. Kaiser NW has been among the more progressive commercial insurers in covering GLP-1s for both diabetes and weight management indications.

The Oregon Board of Pharmacy regulates compounding under USP standards. Oregon has licensed compounding pharmacies in the Portland area and other urban centers. Out-of-state 503B outsourcing facilities can ship compounded semaglutide to Oregon. Oregon has taken a science-based approach to compounding regulation, neither overly restrictive nor permissive.